185 related articles for article (PubMed ID: 17213229)
1. Inflammatory, haemostatic, and rheological markers for incident peripheral arterial disease: Edinburgh Artery Study.
Tzoulaki I; Murray GD; Lee AJ; Rumley A; Lowe GD; Fowkes FG
Eur Heart J; 2007 Feb; 28(3):354-62. PubMed ID: 17213229
[TBL] [Abstract][Full Text] [Related]
2. Relative value of inflammatory, hemostatic, and rheological factors for incident myocardial infarction and stroke: the Edinburgh Artery Study.
Tzoulaki I; Murray GD; Lee AJ; Rumley A; Lowe GD; Fowkes FG
Circulation; 2007 Apr; 115(16):2119-27. PubMed ID: 17404162
[TBL] [Abstract][Full Text] [Related]
3. Plasma fibrinogen, haemostatic factors and prediction of peripheral arterial disease in the Edinburgh Artery Study.
Smith FB; Lee AJ; Hau CM; Rumley A; Lowe GD; Fowkes FG
Blood Coagul Fibrinolysis; 2000 Jan; 11(1):43-50. PubMed ID: 10691098
[TBL] [Abstract][Full Text] [Related]
4. Symptomatic peripheral arterial disease in women: nontraditional biomarkers of elevated risk.
Pradhan AD; Shrivastava S; Cook NR; Rifai N; Creager MA; Ridker PM
Circulation; 2008 Feb; 117(6):823-31. PubMed ID: 18227386
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study.
Tzoulaki I; Murray GD; Lee AJ; Rumley A; Lowe GD; Fowkes FG
Circulation; 2005 Aug; 112(7):976-83. PubMed ID: 16087797
[TBL] [Abstract][Full Text] [Related]
6. Hemostatic factors, inflammatory markers, and progressive peripheral atherosclerosis: the Edinburgh Artery Study.
Tzoulaki I; Murray GD; Price JF; Smith FB; Lee AJ; Rumley A; Lowe GD; Fowkes FG
Am J Epidemiol; 2006 Feb; 163(4):334-41. PubMed ID: 16357107
[TBL] [Abstract][Full Text] [Related]
7. Prospective evaluation of the relationship between C-reactive protein, D-dimer and progression of peripheral arterial disease.
Musicant SE; Taylor LM; Peters D; Schuff RA; Urankar R; Landry GJ; Moneta GL
J Vasc Surg; 2006 Apr; 43(4):772-80; discussion 780. PubMed ID: 16616235
[TBL] [Abstract][Full Text] [Related]
8. Ankle-brachial index and hemostatic markers in the Atherosclerosis Risk in Communities (ARIC) study cohort.
Reich LM; Heiss G; Boland LL; Hirsch AT; Wu K; Folsom AR
Vasc Med; 2007 Nov; 12(4):267-73. PubMed ID: 18048462
[TBL] [Abstract][Full Text] [Related]
9. Comparison of levels of inflammatory markers and hemostatic factors in the patients with and without peripheral arterial disease.
Unlü Y; Karapolat S; Karaca Y; Kiziltunç A
Thromb Res; 2006; 117(4):357-64. PubMed ID: 15890391
[TBL] [Abstract][Full Text] [Related]
10. Relation of inflammation to peripheral arterial disease in the national health and nutrition examination survey, 1999-2002.
Wildman RP; Muntner P; Chen J; Sutton-Tyrrell K; He J
Am J Cardiol; 2005 Dec; 96(11):1579-83. PubMed ID: 16310445
[TBL] [Abstract][Full Text] [Related]
11. Fibrinogen, factor VII and PAI-1 genotypes and the risk of coronary and peripheral atherosclerosis: Edinburgh Artery Study.
Lee AJ; Fowkes FG; Lowe GD; Connor JM; Rumley A
Thromb Haemost; 1999 Apr; 81(4):553-60. PubMed ID: 10235438
[TBL] [Abstract][Full Text] [Related]
12. Relationship of monocyte count and peripheral arterial disease: results from the National Health and Nutrition Examination Survey 1999-2002.
Nasir K; Guallar E; Navas-Acien A; Criqui MH; Lima JA
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1966-71. PubMed ID: 15976323
[TBL] [Abstract][Full Text] [Related]
13. D-dimer, inflammatory markers, and lower extremity functioning in patients with and without peripheral arterial disease.
McDermott MM; Greenland P; Green D; Guralnik JM; Criqui MH; Liu K; Chan C; Pearce WH; Taylor L; Ridker PM; Schneider JR; Martin G; Rifai N; Quann M; Fornage M
Circulation; 2003 Jul; 107(25):3191-8. PubMed ID: 12810614
[TBL] [Abstract][Full Text] [Related]
14. Tissue plasminogen activator antigen and D-dimer as markers for atherothrombotic risk among healthy postmenopausal women.
Pradhan AD; LaCroix AZ; Langer RD; Trevisan M; Lewis CE; Hsia JA; Oberman A; Kotchen JM; Ridker PM
Circulation; 2004 Jul; 110(3):292-300. PubMed ID: 15238458
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of peripheral arterial disease in high risk subjects and coronary or cerebrovascular patients.
Poredos P; Jug B
Angiology; 2007; 58(3):309-15. PubMed ID: 17626985
[TBL] [Abstract][Full Text] [Related]
16. [Underrecognized peripheral arterial disease in patients with acute coronary syndrome: prevalence of traditional and emergent cardiovascular risk factors].
Huelmos A; Jiménez J; Guijarro C; Belinchón JC; Puras E; Sánchez C; Casas ML; López-Bescos L
Rev Esp Cardiol; 2005 Dec; 58(12):1403-10. PubMed ID: 16371199
[TBL] [Abstract][Full Text] [Related]
17. Association between C-reactive protein level and peripheral arterial disease among US adults without cardiovascular disease, diabetes, or hypertension.
Shankar A; Li J; Nieto FJ; Klein BE; Klein R
Am Heart J; 2007 Sep; 154(3):495-501. PubMed ID: 17719297
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for progression of peripheral arterial disease in large and small vessels.
Aboyans V; Criqui MH; Denenberg JO; Knoke JD; Ridker PM; Fronek A
Circulation; 2006 Jun; 113(22):2623-9. PubMed ID: 16735675
[TBL] [Abstract][Full Text] [Related]
19. Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study.
Morange PE; Bickel C; Nicaud V; Schnabel R; Rupprecht HJ; Peetz D; Lackner KJ; Cambien F; Blankenberg S; Tiret L;
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2793-9. PubMed ID: 17023678
[TBL] [Abstract][Full Text] [Related]
20. D-dimer and inflammatory markers as predictors of functional decline in men and women with and without peripheral arterial disease.
McDermott MM; Ferrucci L; Liu K; Criqui MH; Greenland P; Green D; Guralnik JM; Ridker PM; Taylor LM; Rifai N; Tian L; Zheng J; Pearce WH; Schneider JR; Vonesh E
J Am Geriatr Soc; 2005 Oct; 53(10):1688-96. PubMed ID: 16181167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
